PROKYMA

ProKyma develops cell separation technology to improve molecular biology tests. ProKyma’s own focus lies in developing an improved blood test for Circulating Tumour Cells (CTC's) to improve detection of early metastasis of cancers and subsequent monitoring of the response to therapy. The company is a spinout from Dstl Porton Down, to exploit Dstl’s research into separation technologies. The company’s expertise lies in the use of high frequency ultrasound along with magnetism to manipulate, concentrate, and purify biological cells from complex samples – a technique that has diverse applications in the clinical, food, environmental, and pharmaceutical sectors.

#SimilarOrganizations #People #Financial #Website #More

PROKYMA

Social Links:

Linkedin

Industry:

Biotechnology Medical Medical Device

Address:

Liverpool, Liverpool, United Kingdom

Country:

United Kingdom

Website Url:

http://www.prokyma.com

Total Employee:

1+

Status:

Closed

Total Funding:

0

Technology used in webpage:

Nginx PHP Baidu Analytics

Similar Organizations

aebi-accelerated-evolution-biotechnologies-logo

AEBi - Accelerated Evolution Biotechnologies

AEBi is engaged in the discovery and development of therapeutic peptides.

xcelens-logo

Xcelens

Xcelens is engaged in Design, manufacture and marketing of medical devices.

Founder

damian-bond_image

Damian Bond

Investors List

nesta-investments_image

Nesta Ventures

Nesta Ventures investment in Venture Round - ProKyma

national-institute-for-health-research_image

National Institute for Health Research

National Institute for Health Research investment in Grant - ProKyma

Official Site Inspections

http://www.prokyma.com

Host Informations
Whois Informations

Loading ...

More informations about "ProKyma" on Search Engine